Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

Published:2023-06 Issue:6 Volume:29 Page:1389-1399
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Magen Assaf^ORCID,Hamon Pauline,Fiaschi Nathalie,Soong Brian Y.,Park Matthew D.,Mattiuz Raphaël^ORCID,Humblin Etienne,Troncoso Leanna^ORCID,D’souza Darwin,Dawson Travis^ORCID,Kim Joel,Hamel Steven,Buckup Mark,Chang Christie,Tabachnikova Alexandra,Schwartz Hara,Malissen Nausicaa,Lavin Yonit,Soares-Schanoski Alessandra,Giotti Bruno,Hegde Samarth,Ioannou Giorgio,Gonzalez-Kozlova Edgar^ORCID,Hennequin Clotilde,Le Berichel Jessica,Zhao Zhen,Ward Stephen C.,Fiel Isabel,Kou Baijun,Dobosz Michael,Li Lianjie,Adler Christina,Ni Min,Wei Yi,Wang Wei,Atwal Gurinder S.,Kundu Kunal,Cygan Kamil J.^ORCID,Tsankov Alexander M.,Rahman Adeeb,Price Colles,Fernandez Nicolas,He Jiang,Gupta Namita T.^ORCID,Kim-Schulze Seunghee,Gnjatic Sacha^ORCID,Kenigsberg Ephraim^ORCID,Deering Raquel P.,Schwartz Myron^ORCID,Marron Thomas U.^ORCID,Thurston Gavin^ORCID,Kamphorst Alice O.,Merad Miriam^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-023-02345-0.pdf

Reference72 articles.

1. Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M. & Roayaie, S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann. Surg. 261, 947–955 (2015).

2. Shindoh, J. et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford) 15, 31–39 (2013).

3. Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566–576 (2020).

4. Forde, P. M. et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N. Engl. J. Med. 378, 1976–1986 (2018).

5. Huang, A. C. et al. A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma. Nat. Med. 25, 454–461 (2019).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans;Current Opinion in Immunology;2024-12

2. Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma;Gut;2024-09-11

3. Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phase 1 trial;2024-09-11

4. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

5. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09